Please login to the form below
ESMO congress
This page shows the latest ESMO congress news and features for those working in and with pharma, biotech and healthcare.
AstraZeneca’s phase 3 liver cancer study shows continued survival benefit
The updated results from the study, which were presented at this year’s European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer, show that treatment plan reduced the risk
Latest news
-
Regeneron’s fianlimab/Libtayo combination shows positive results in advanced melanoma treatment
The results were shared at the European Society for Medical Oncology Congress 2022. ... The results, which were shared in a mini-oral session at the European Society for Medical Oncology (ESMO) Congress 2022 in Paris, showed the combination treatment
-
Novartis and BeiGene announce positive phase 3 trial results for hepatocellular carcinoma treatment
European Society for Medical Oncology (ESMO) Congress on 10 September.
-
FDA grants Enhertu Breakthrough Therapy Designation in breast cancer
Phase 3 trial data presented at ESMO shows Enhertu significantly reduced the risk of disease progression or death. ... The FDA granted BTD based on data from the DESTINY-Breast03 phase 3 trial presented during the European Society for Medical Oncology
-
New data advances AstraZeneca’s “revolution in oncology”
More Imfinzi data will be presented at the European Society for Medical Oncology (ESMO) Congress, showing three-year overall survival data in extensive-stage small cell lung cancer (ES-SCLC), the ... At ESMO, the company will present results from the
-
Imugene’s cancer vaccine shows promise in mid-stage stomach cancer trial
The new mid-stage data, presented at the ESMO World Congress on Gastrointestinal Cancer 2021 annual meeting, showed that HER-Vaxx plus chemotherapy resulted in an overall response rate of 50%
More from news
Approximately 1 fully matching, plus 33 partially matching documents found.
Latest Intelligence
-
Putting the ovation into innovation: trends from ESMO
The European Society for Medical Oncology (ESMO) held its 2022 congress in Paris in September. ... 1. The crowds are coming back. This was ESMO’s first in-person congress since the pandemic disruption and the crowd numbers suggest that delegates
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Precision versus personalised medicine
ESMO Daily Reporter. CAR-T-cell therapy. Available at: . Accessed November 2022. Qin VM, et al. Cancers (Basel).2021; 13:404. Petersen BS, et al.
-
Creative review: ESMO 2018
BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring ... On October 19th the team from Blue Latitude Health
-
ESMO 2012 Video and Social Media Highlights
Brandcast Health's take on the highlights from the ESMO 2012 congress in Vienna, Austria, including social media insights.
-
Blue Latitude Health
As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. ... BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- Top 10 benefits of virtual advisory boards: Save Time and Resources
- NIHR launches new framework to highlight health progress outcomes
- Johns Hopkins and National Cancer Unit develop new genetic risk-scoring method for major diseases
- UKHSA secures UK-based vaccine deal for future influenza pandemics
- Novo Nordisk and Valo Health agree deal worth up to $3.3bn to develop cardiovascular treatments
- Landscape review reveals £1.1bn of UK funding for rare diseases
No results were found
PMHub
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
